Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Oct 2026 for ABIVAX, €105k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Corinna zur Bonsen-Thomas: trading record in brief
Corinna zur Bonsen-Thomas, listed as chief executive, appears in our data through filings on Abivax shares, published by AMF. Between 26 April 2024 and 29 September 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 1 October 2026 came the latest disclosure, an option exercise for €105k in Abivax. Typically, a trade is published a median of 41 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from AMF. Past trades are no guide to future returns.
Companies and markets linked to Corinna zur Bonsen-Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
11,113 shares@ €9.46690.0014% mcap30.5% of flowWarrants 2024-1 / 2025-1Euronext ParisISIN FR00123332842026DD1141576
16,400 shares@ €11.5779.1% of flowwarrantsEuronext ParisISIN FR00123332842025DD1072558
19,455 shares@ €2.5720.9% of flowBSA warrantsHors plateforme de négociationISIN FR00123332842025DD1018475
3 of 3 declarations
